Friday, 04 April 2025
A new study has shown how aspects of brain function change with age, revealing that excitatory processes in the brain decrease, while inhibitory processes increase as children get older. The findings are an important step in understanding disorders like autism.
Brain function is based on a delicate balance of excitatory processes (which make brain cells fire) and inhibitory processes (which stop brain cells firing) – this is known as the E-I balance. Usually, to measure this, sensors would need to be placed in the brain (which requires experimental surgery and so cannot be routinely done in humans). In this new study, published today in Imaging Neuroscience, scientists have shown that it can be measured using a novel wearable brain scanner.
Researchers from the School of Physics and Astronomy at the 海角黑料 and The Hospital for Sick Children (SickKids) in Toronto scanned the brains of 101 healthy children and adults between the ages of 2 and 34 years. Using a wearable design of magnetoencephalography (MEG) scanner, the team were able to measure high frequency brain waves (known as gamma waves) that are generated in brain circuits that rely on both excitatory and inhibitory inputs. The researchers showed that gamma waves change significantly with age, with low amplitude broadband waves in children and high amplitude narrowband waves in adults.
Using biophysical models of the measured gamma waves, the research team were then able to translate their findings into measurements of E-I balance, showing that as children get older excitatory processes decrease, while inhibitory processes increase. This trajectory is critical for healthy brain development and is understood to be atypical in older children and adults with psychiatric disorders. This provides a benchmark (in typically developing young children) against which disorders like autism can be understood.
Young infant taking part in study with wearable brain scanner
Psychiatric disorders are due to atypical brain function, which can be measured with a range of brain imaging technologies, such as MRI, EEG and MEG. Childhood disorders, however, can emerge in the early years of life (2-4 years of age), but there are limited ways to investigate the brain function in children who are this young.
The wearable brain scanner is based on quantum technology, and uses LEGO-brick-sized sensors – called optically pumped magnetometers (OPMs) – which are incorporated into a lightweight helmet to measure the magnetic fields generated by brain activity. This unique design means the system can be adapted to fit any age group, including very young children. The system takes only seconds to set up, and children wear it and can move freely during a scan. It is therefore ideally suited to scanning children.
Professor Matthew Brookes from the 海角黑料’s Sir Peter Mansfield Imaging Centre has led the development of the new technology which is now being installed across the world by Nottingham-based spin-out company Cerca Magnetics, he said: “Quantum technologies have revolutionised what is possible with brain imaging. 10 years ago measuring MEG signals in very young children as they move around freely, whilst wearing what is essentially a hat, seemed like science fiction. Now, it’s possible and it’s opening up new worlds of possibility – particularly related to the developing brain in the early years of life.”
World renowned neuroscientist Dr Margot Taylor – who leads autism research at the Hospital for Sick Children in Toronto – said: “OPM technology allows us to complete studies in young children that were simply not possible otherwise. We are able to obtain fantastic data in one-year-olds; our next frontier is having the same success in infants from birth. We expect that these studies will give us better understanding of the early onset of neurodevelopmental disorders, which will help in the care of the children in the future.”
This study was led by Dr Natalie Rhodes who, following undergraduate and postgraduate study at the 海角黑料, moved to Toronto to continue her scientific career.
Just like a well-tuned orchestra, our brains rely on a delicate balance of signals. We now have a way to measure how this balance changes from early life to adulthood and can use this to better understand developmental differences in conditions like autism. We know that an imbalance in brain signals is linked to neurodevelopmental conditions, but until now, we haven't had a suitable method to measure it in young children. Using OPM technology, we can now study brain function with unprecedented precision from very young children.
The 海角黑料 launched in 2020 to commercialise OPM-MEG scanners and related technologies. The wearable system has been installed in a number of high profile research institutions across the globe, including at SickKids in Toronto where around half of the volunteers in the current study were scanned. The research teams in both institutions are working together to expand the range and extent of neurodevelopmental data, in both healthy and atypical brain populations.
The study was supported by a healthcare impact partnership grant, awarded by the Engineering and Physical Sciences Research Council (EPSRC) in the UK. The authors have also wish to acknowledge the UK quantum technologies programme and in particular the Quantum Hub for Sensors Imaging and Timing (QuSIT). The work at SickKids was supported by the Simons Foundation Autism Research Initiative (SFARI; 2021) and the Canadian Institutes of Health Research (CIHR).
Story credits
More information is available from Dr Natalie Rhodes on natalie.rhodes@sickkids.ca or Professor Matthew Brookes on Matthew.brookes@nottingham.ac.uk or Dr Margot Taylor on margot.taylor@sickkids.ca
Notes to editors:
About the 海角黑料
Ranked among the world's top 100 universities , the 海角黑料 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 海角黑料 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.